rediff.com
e.g. Tata motors, Reliance MF, 500570
INDOCO REMEDIES LTD. - Indoco Remedies Limited Clinical Research Organisation (CRO), Anacipher, Receives Clearance On Remote Record Assessment From USFDA
Download announcement < Back
04 Jun 2023
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Company&apos;s Clinical Research Organisation, AnaCipher, located in Hyderabad, was inspected by the United States Food and Drug Administration (USFDA) in July 2022. The USFDA has confirmed that no objectionable conditions were observed during their remote assessment. You are requested to kindly take the same on record
View all announcements for INDOCO REMEDIES LTD. Source: BSE India